AngioDynamics Announces Trial Date Of March 12, 2007 In Diomed Patent Litigation

QUEENSBURY, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that U.S. District Judge Nathaniel M. Gorton has set March 12, 2007 as the start date for the jury trial in the Diomed patent litigation. The trial will be held in the Federal District Court in Boston, Massachusetts, and legal arguments are expected to last between two and three weeks. In January 2004 Diomed, Inc., a subsidiary of Diomed Holdings, Inc., filed a lawsuit against AngioDynamics alleging patent infringement related to AngioDynamics’ VenaCure® product line. VenaCure is a laser system used for the treatment of severe varicose veins. The lawsuit involves a single U.S. patent, number 6,398,777, covering a specific method of endovascular laser treatment of varicose veins.
MORE ON THIS TOPIC